2019 American Transplant Congress
Individualized Preconditioning for ABO-Incompatible Living Donor Kidney Transplantation: An Initial Report of 48 Cases from China
*Purpose: Typically, the majority of centres that perform ABO incompatible (ABOi) kidney transplantation use fixed preconditioning protocols regardless of the initial titer. As experience in…2019 American Transplant Congress
Pushing the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death
*Purpose: Controlled donation after circulatory death (cDCD) has allowed to significantly increase the deceased donors pool. However, while excellent previous reports have been shown using…2019 American Transplant Congress
Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning
HealthTech Solutions, Inc., Coralville, IA
*Purpose: To better predict outcomes of graft survival in kidney donation and ultimately save more lives for those waiting on the list.*Methods: Machine learning methods…2019 American Transplant Congress
Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation
Kidney Transplant, Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Recent observations suggest that the use of IVIg + rituximab has a critical role in modifying allo-reactive B-cells prior to HLAi kidney transplantation, thus…2019 American Transplant Congress
Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant
Ochsner Clinic Foundation, New Orleans, LA
*Purpose: As a consequence of natural immunosenescence, elderly patients may not require as potent immunosuppression as their younger counterparts. Optimal induction regimens in this population,…2019 American Transplant Congress
Retrospective Evaluation of Dapsone Prophylaxis Complications in Kidney Transplant Recipients
*Purpose: Secondary options for Pneumocystis Jirovecii pneumonia (PJP) prophylaxis in kidney transplant recipients (KTRs) include atovaquone or dapsone. Atovaquone use may be limited by cost/side…2019 American Transplant Congress
Risk of Opportunistic Infection in Kidney Transplant Recipients with Cytomegalovirus Infection and Associated Outcomes
*Purpose: Cytomegalovirus (CMV) infection in kidney transplant recipients has been anecdotally observed with concomitant or subsequent opportunistic infections (OI), but this association has yet to…2019 American Transplant Congress
Outcomes after Prolonged Therapeutic Plasma Exchange in Pediatric Kidney Transplant Patients with Early Recurrence of Focal Segmental Glomerular Sclerosis
*Purpose: Focal segmental glomerular sclerosis (FSGS) is the most common cause of glomerulonephritis leading to end-stage renal disease (ESRD) in pediatric patients. FSGS recurs frequently…2019 American Transplant Congress
Changing Education Paradigms: Training Fellows for High Stake Procedures
*Purpose: Living kidney donation is unique, as healthy patients are placed at risks inherent with major surgery without physical benefit. The procedure receives intense scrutiny…2019 American Transplant Congress
Kidney Transplant Recipient Outcomes from Living Donors with Stones
Indiana University School of Medicine, Indianapolis, IN
*Purpose: 0 0 1 323 1842 Indiana University 15 4 2161 14.0 Normal 0 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable…
- « Previous Page
- 1
- …
- 194
- 195
- 196
- 197
- 198
- …
- 214
- Next Page »